LLY compared with GOSS: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

GOSSGossamer Bio, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

GOSSGossamer Bio, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only GOSS 3

—Chiesiunlistedcustomer

—Pulmokineunlistedsupplier

—Respira Therapeuticsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

LLYELI Lilly & Co

1,371.32· pre 1,346.78· delayed

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

GOSSGossamer Bio, Inc.

9.31· pre 9.42· delayed

Pre-marketNov 6 '26delayed

Mkt cap$57.6MRevenue$9MQ2 FY26Revenue$48MFY25

Compare

Pre-marketNov 6 '26delayed

LLYELI Lilly & Co

GOSSGossamer Bio, Inc.

1,371.32pre 1,346.78delayed

Price

9.31pre 9.42delayed

$1.2T

Mkt cap

$57.6M

Q3 FY26$24.4B

Revenue

$9MQ2 FY26

FY25$65.2B

Revenue

$48MFY25

LLY1,371.32vsGOSS9.31Pre-marketNov 6 '26delayed